
Aerospace and defense company Cadre (NYSE:CDRE) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 42.5% year on year to $155.9 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $627 million at the midpoint. Its non-GAAP profit of $0.38 per share was 37% above analysts’ consensus estimates.
Is now the time to buy CDRE? Find out in our full research report (it’s free for active Edge members).
Cadre (CDRE) Q3 CY2025 Highlights:
- Revenue: $155.9 million vs analyst estimates of $160.2 million (42.5% year-on-year growth, 2.7% miss)
- Adjusted EPS: $0.38 vs analyst estimates of $0.28 (37% beat)
- Adjusted EBITDA: $29.82 million vs analyst estimates of $27.66 million (19.1% margin, 7.8% beat)
- The company reconfirmed its revenue guidance for the full year of $627 million at the midpoint
- EBITDA guidance for the full year is $114 million at the midpoint, in line with analyst expectations
- Operating Margin: 12%, up from 5% in the same quarter last year
- Market Capitalization: $1.73 billion
StockStory’s Take
Cadre’s third quarter results were met positively by the market, reflecting strong operational execution and notable progress in both core and emerging business areas. Management attributed the quarter’s performance to broad-based margin improvements across major categories, fueled by disciplined pricing, favorable product mix, and productivity initiatives. CEO Warren Kanders pointed to robust demand for explosive ordnance disposal (EOD) products and a significant $20 million sequential increase in backlog as key contributors. The recent Blast Exposure Monitoring System award—a $50 million contract with the U.S. Department of Defense—was highlighted as a milestone achievement for the company’s Med-Eng unit.
Looking ahead, Cadre’s guidance is underpinned by expectations of continued momentum in core markets and the anticipated benefits of the TYR Tactical acquisition. Management emphasized the company’s ability to integrate complementary businesses, expand market reach, and leverage advanced manufacturing capabilities, particularly in armor solutions. CFO Blaine Browers noted that while the addition of TYR Tactical may introduce some short-term gross margin pressure from integration costs, the transaction is expected to be accretive to adjusted EBITDA. The leadership team is also monitoring government spending patterns and large contract opportunities, with President Brad Williams stating, “We feel like we’ve got any of those potential slippages covered in the Q4 guidance side of things.”
Key Insights from Management’s Remarks
Cadre’s latest quarter benefited from strong demand in core safety segments, enhanced by backlog growth and strategic M&A, while management highlighted broad improvements across business units.
- Margin expansion across categories: Management credited broad-based gross margin improvements to pricing discipline, productivity initiatives, and a positive sales mix, with CFO Blaine Browers stressing that gains were not isolated to a single business line.
- Backlog growth signals momentum: President Brad Williams highlighted a $20 million sequential increase in organic backlog, mainly driven by the booking of previously delayed large opportunities, supporting confidence in near-term revenue visibility.
- Major contract wins: The Med-Eng business secured the Blast Exposure Monitoring System (BEMO) contract, a $50 million IDIQ with the U.S. Department of Defense, positioning Cadre as a leader in blast sensor technology and opening up potential international opportunities.
- Strategic M&A accelerates diversification: The pending acquisition of TYR Tactical, a manufacturer of advanced protective equipment with minimal customer overlap, aligns with Cadre’s strategy to enter high-margin, global markets and adds significant pressing capabilities to the armor business.
- Innovation and new product traction: Recent launches, such as the HyperX tactical carrier and Safariland SX HP armor, received strong customer feedback and are gaining traction in core law enforcement and military markets, supporting Cadre’s strategy of portfolio refreshment.
Drivers of Future Performance
Management expects Cadre’s performance in upcoming quarters to hinge on successful integration of acquisitions, execution on large contracts, and resilience in government-related demand.
- TYR Tactical integration impact: Leadership anticipates that integrating TYR Tactical will provide access to new international customers and advanced manufacturing resources, though near-term GAAP gross margins may face pressure from acquisition-related amortization. Adjusted EBITDA, however, is expected to benefit from the combination.
- Backlog conversion and contract execution: With a substantial increase in backlog and several large government contracts in the pipeline, Cadre’s ability to deliver on these orders efficiently will be a major determinant of revenue growth and profitability in the next year.
- Exposure to government spending cycles: Management highlighted continued monitoring of government shutdown risks and funding delays, particularly in nuclear and law enforcement markets. While these risks were incorporated into current guidance, further disruptions could affect delivery schedules and new bookings.
Catalysts in Upcoming Quarters
In the upcoming quarters, the StockStory team will be closely monitoring (1) the pace and profitability of integrating TYR Tactical into Cadre’s platform, (2) the conversion of large backlog orders—especially the BEMO contract—into realized revenue, and (3) the company’s ability to mitigate any disruptions from government spending delays or shutdowns. Progress in these areas will be critical to sustaining margin expansion and growth.
Cadre currently trades at $44.21, up from $42.60 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free for active Edge members).
Our Favorite Stocks Right Now
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.